Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway. (Q53637693)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway. |
scientific article |
Statements
Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway. (English)
1 reference
Mengzan Wang
1 reference
Zhiyuan Li
1 reference
Xiaohong Zhang
1 reference
Xinxing Xie
1 reference
Yujiao Zhang
1 reference
Ximin Wang
1 reference
Yinglong Hou
1 reference
13 December 2014
1 reference
24
1 reference
4
1 reference
386-394
1 reference
Identifiers
1 reference